scholarly journals Disease Control as a Predictor of Survival with Gefitinib and Docetaxel in a Phase III Study (V-15-32) in Advanced Non-small Cell Lung Cancer Patients

2010 ◽  
Vol 5 (7) ◽  
pp. 1042-1047 ◽  
Author(s):  
Nobuyuki Yamamoto ◽  
Yutaka Nishiwaki ◽  
Shunichi Negoro ◽  
Haiyi Jiang ◽  
Yohji Itoh ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Disease Control ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase Iii ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Phase Iii Study

RANIDO: A phase III clinical trial of racotumomab-alum or nimotuzumab versus docetaxel in advanced non-small cell lung cancer patients.

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. TPS3111-TPS3111
Author(s):  
Maurenis Hernandez ◽  
Eduardo Rafael Santiesteban ◽  
Ramon Alberto Ortiz ◽  
Elia Neninger ◽  
Soraida Acosta ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Clinical Trial ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase Iii ◽  
Small Cell Lung ◽  
Phase Iii Clinical Trial ◽  
Lung Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document